Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2015) 37 GP05.04 | DOI: 10.1530/endoabs.37.GP.05.04

ECE2015 Guided Posters Developmental and paediatric endocrinology (10 abstracts)

Pilot study on the effects of cross-sex hormone treatment in transsexual persons on metabolism by means of metabolomics profiling

Matthias K Auer 1 , Tao Xu 2 , Yasmin Roepke 1 , Günter K Stalla 1 , Mareike Stieg 1 , Eva Van Caenegem 4 , Cornelia Prehn 3 , Rui Wang-Sattler 2 , Jerzy Adamski 3 & Guy T’sjoen 4

1Endocrinology, Diabetology and Internal Medicine, Max Planck Institute of Psychiatry, Munich, Germany; 2Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, Neuherberg, Germany; 3Institute of Experimental Genetics, Genome Analysis Center, German Center for Diabetes Research, Neuherberg, Germany; 4Department of Endocrinology, Ghent University Hospital, Ghent, Belgium.

Introduction: Sex steroid hormones exert a wide range of effects on metabolism. New techniques such as metabolomic profiling allow for a deeper insight into metabolic regulation. In epidemiological samples it has been demonstrated that most of these metabolites show sex-specific differences. However, if these differences are attributable to the effects of sex hormones or genetics is little understood so far.

Methods: We performed targeted metabolomics profiling in serum of fasting transmen (F2M) and transwomen (M2F) at baseline and following 12 months of cross-sex hormone treatment (n=20/group). Subjects investigated in this study were part of the European Network for the Investigation of Gender Incongruence (ENIGI). The targeted metabolomics approach was based on ESI–LC–MS/MS measurements by AbsoluteIDQTM p180 Kit (Biocrates Life Sciences AG).

Results: Several metabolites concentrations changed significantly between the two visits in the M2F group including DL-carnitine, octadecanyl-L-carnithine, threonine, alpha-amino adipic acid, hydroxyproline, phosphatidylcholine diacyl C34:3, ornithine, citrulline, and ornithine/arginine ratio (FDR <0.05, P<0.05). In the F2M group there was only a significant change in ornithine. After adjustment for age, lifestyle factors and body composition in a linear mixed effects model, these results remained significant but vanished after adjusting for sex hormone levels. This indicates a direct effect of sex hormones on metabolite levels. Opposite effects were seen, i.e. for changes in ornithine levels between the two groups. Ornithine was further strongly positively related to testosterone levels in both groups. These findings are also in line with the sex-specific dimorphism for metabolites observed in epidemiological studies.

Conclusion: In this first pilot study we could show that cross-sex hormone treatment induces several changes in serum metabolites. Our findings indicate a direct effect of sex hormones on different metabolic cycles including lipid metabolism, nitric oxide formation, and amino acid regulation.

Article tools

My recent searches

No recent searches.